-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Intra-Cellular Therapies, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
- Intra-Cellular Therapies, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$16.2M, a 62.1% increase year-over-year.
- Intra-Cellular Therapies, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$84.3M, a 54.3% increase year-over-year.
- Intra-Cellular Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$140M, a 45.5% increase from 2022.
- Intra-Cellular Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$256M, a 9.81% increase from 2021.
- Intra-Cellular Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$284M, a 25.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)